Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis

被引:0
作者
L. Karlsson
J. Lundkvist
E. Psachoulia
M. Intorcia
O. Ström
机构
[1] Quantify Research,Department of Learning, Informatics, Management and Ethics (LIME), Medical Management Centrum (MMC)
[2] Karolinska Institutet,Department of Pharmacy
[3] Uppsala University,undefined
[4] Amgen (Europe) GmbH,undefined
来源
Osteoporosis International | 2015年 / 26卷
关键词
Bisphosphonates; Denosumab; Meta-analysis; Persistence; Retrospective; Review;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2401 / 2411
页数:10
相关论文
共 332 条
[51]  
Compston J(2013)Differences in adherence to osteoporosis regimens: a 2-year analysis of a population treated under specific guidelines Clin Ther 182 601-570
[52]  
Cooper C(2006)Channeling and adherence with alendronate and risedronate among chronic glucocorticoid users Osteoporos Int 31 562-322
[53]  
Stenmark J(2013)Comparison of prescribing and adherence patterns of anti-osteoporotic medications post-admission for fragility type fracture in an urban teaching hospital and a rural teaching hospital in Ireland between 2005 and 2008 Ir J Med Sci 50 315-875
[54]  
McCloskey EV(2013)Persistence with osteoporosis medication among newly-treated osteoporotic patients J Bone Miner Metab 50 870-848
[55]  
Jonsson B(2012)Persistence and compliance of medications used in the treatment of osteoporosis—analysis using a large scale, representative, longitudinal German database Int J Clin Pharmacol Ther 6 839-59
[56]  
Kanis JA(2012)Medication adherence and fracture risk among patients on bisphosphonate therapy in a large United States health plan Bone 14 276-1594
[57]  
Gnant M(2013)Discontinuation and reinitiation patterns of osteoporosis treatment among commercially insured postmenopausal women Int J Gen Med 19 50-122
[58]  
Pfeiler G(2013)Adherence to osteoporosis regimens among men and analysis of risk factors of poor compliance: a 2-year analytical review BMC Musculoskelet Disord 20 1583-1021
[59]  
Dubsky PC(2013)Patterns of osteoporosis treatment change and treatment discontinuation among commercial and medicare advantage prescription drug members in a national health plan J Eval Clin Pract 10 118-undefined
[60]  
Hubalek M(2009)Adherence to weekly oral bisphosphonate therapy: cost of wasted drugs and fractures Osteoporos Int 335 1016-undefined